Bivalirudin Market
Bivalirudin Market Scope: Industry Analysis, Market Size, Growth, Trends Till 2031
Request Sample Report
Bivalirudin Market Size and Growth
The global Bivalirudin market research report highlights current market conditions and trends. Bivalirudin market size is projected to grow at a steady rate due to increasing prevalence of cardiovascular diseases and rise in adoption of anticoagulant therapy. Key players are focusing on product advancements and strategic collaborations to gain a competitive edge. Request Sample Report
Companies Covered (Covid 19 Impact Covered)
◍ Bachem
◍ Teva Pharmaceutical Industries
◍ Ambiopharm
◍ ChemWerth
◍ ScinoPharm
◍ Salubris
◍ Suzhou No.4 Pharmaceutical Factory
◍ SOHO-YIMING Pharmaceuticals
The bivalirudin market is competitive with key players such as Bachem, Teva Pharmaceutical Industries, Ambiopharm, ChemWerth, ScinoPharm, Salubris, Suzhou No.4 Pharmaceutical Factory, and SOHO-YIMING Pharmaceuticals. These companies produce and distribute bivalirudin, a direct thrombin inhibitor used in patients undergoing cardiac procedures, contributing to the growth of the market.
- Bachem reported sales revenue of $253 million in 2020.
- Teva Pharmaceutical Industries reported sales revenue of $16.6 billion in 2020.
- Ambiopharm reported sales revenue of $88.7 million in 2019.
Request Sample Report
Market Segmentation
By Application
◍ Thrombin Inhibitor
◍ Application 2
By Product
◍ ≥ 99.0%
◍ ＜ 99.0%
Request Sample Report
$ X Billion USD
Market Growth
Request Sample Report
THANK YOU Email : sales@reportprime.com USA : +1 507 500 7209 Website : https://www.reportprime.com/ Request Sample Report Contact US Our Clients